News
The National Heart, Lung, and Blood Institute (NHLBI) has released the first comprehensive, evidence-based guidelines for management of sickle cell disease from birth to end of life, based on ...
Thirty-three states, the District of Columbia, and Puerto Rico will participate in CMS’ voluntary Cell and Gene Therapy (CGT) ...
DALLAS – September 9, 2014– The National Heart, Lung, and Blood Institute (NHLBI) has released the first comprehensive, evidence-based guidelines for management of sickle cell disease from ...
SAN DIEGO — Guideline-directed use of hydroxyurea may reduce cerebrovascular disease among individuals with sickle cell disease, according to single-center study results.However, further ...
NHLBI's sickle cell branch chief and senior investigator Swee Lay Thein is leading the trial, which is being conducted at the NIH Clinical Center in Bethesda, Maryland.
Hosted on MSN1mon
WHO issues first ever guidelines for Sickle cell pregnancy - MSNBy Franca OfiliThe World Health Organisation, WHO, has released its first-ever global guideline on the management of Sickle Cell Disease during pregnancy.In a statement issued on Thursday in ...
September is National Sickle Cell Awareness Month.The congressional designation is intended to focus attention on the need for improved treatments and additional research for the condition, which ...
Gregory Kato, M.D., head of NHLBI's Sickle Cell Vascular Disease Section and a co-author on this study, is available to comment on the study's findings and implications for future research.
A guideline for treating individuals with sickle cell disease has been developed by an NHLBI expert panel.
The WHO releases its first global guideline on managing sickle cell disease during pregnancy, addressing critical health challenges for mothers and babies. Learn more.
For the first time scientists have corrected sickle cell disease in mice using gene therapy, according to a study supported by the National Heart, Lung, and Blood Institute (NHLBI) of the National ...
Medical researchers are developing a new surveillance system to determine the number of patients diagnosed with a family of inherited blood disorders known as hemoglobinopathies, including sickle cell ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results